ID
13080
Description
Ophthalmologic Safety of Long Term Treatment With Pramipexole Compared to Bromocriptine or Other Dopamine Agonists in Patients With Parkinson's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02233023
Link
https://clinicaltrials.gov/show/NCT02233023
Keywords
Versions (1)
- 1/15/16 1/15/16 -
Copyright Holder
CC BY-NC 3.0
Uploaded on
January 15, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Parkinson Disease NCT02233023
Eligibility Parkinson Disease NCT02233023
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
patients who have been treated less than two and a half years (i.e. 30 months) with their actual dopamine agonist
Data type
boolean
Alias
- UMLS CUI [1]
- C0178601
Description
ropinirole
Data type
boolean
Alias
- UMLS CUI [1]
- C0244821
Description
hereditary retinal disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0035309
Description
drug-induced retinopathies
Data type
boolean
Alias
- UMLS CUI [1]
- C0035309
Description
diabetic retinopathy
Data type
boolean
Alias
- UMLS CUI [1]
- C0011884
Description
atypical parkinsonian syndromes
Data type
boolean
Alias
- UMLS CUI [1]
- C1868596
Description
informed consent
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C0439801
- UMLS CUI [1,3]
- C0009488
Description
participation in other studies
Data type
boolean
Alias
- UMLS CUI [1]
- C2348568
Similar models
Eligibility Parkinson Disease NCT02233023
- StudyEvent: Eligibility
C0006230 (UMLS CUI [2])
C0178601 (UMLS CUI [3])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])